Cerbios-Pharma SA is a private owned self-financed pharmaceutical company headquartered in Lugano (Switzerland) with more than 40 years of experience in the pharmaceutical industry, active in the field of APIs, HPAPIs, ADCs and Biotechnology. Cerbios also offers exclusive CDMO services for ADCs, HPAPIs and recombinant proteins. Cerbios further expands its service portfolio through its PROVEO division, a fully integrated end-to-end solution for ADCs development and manufacturing.
Ceramaret SA
Ceramaret SA offers high-precision, custom-made components from advanced ceramics (high-purity Alumina, TZP Zirconia, ATZ, ZTA, and Si3N4) to the medical device industry. Components include feedthroughs, insulators, enclosures, and many more. Materials are inert, biocompatible, resistant to wear, heat, aggressive solvents, and more. The company is ISO 9001, ISO 14001, OHSAS 18001, and ISO 13485 certified.
Celonic AG
Celonic is a “Pure Play” Biologics Contract Development Manufacturing Organization (CDMO). Celonic’s mission is to help its customers, primarily small to large Biotech Companies, bring life-saving and improving drugs effectively to the market using innovative, “next generation” bioprocessing technologies such as, process intensification and full-perfusion. Celonic has a state-of-the-art Development and Innovation Center in Basel, Switzerland (headquarters), and clinical and commercial GMP manufacturing facilities in Heidelberg, Germany. At present, more than 500 highly qualified employees work at Celonic.
Ceidos
Bioproduction is complex particularly during cell expansion in bioreactors. Current methods to assess the viability, density and shape of mammalian cells are highly manual and require recurrent sampling. The C-Netics enables non-destructive and label-free analysis in real time. It works coupled to a dedicated single use kit that integrates an analysis cassette with high-end microelectronic sensors. The monitoring can then be run automatically during the entire duration of the cell culture.This allows the detection of anomalies in real-time and can also be used to quickly optimize a process development. | Ceidos offers an automatic laboratory device that improves the biopharmaceutical production process. Faced with the challenge of slow, manual control of cell cultures, Ceidos introduces the C-Netics, a sophisticated device compatible with most bioreactors. It enables automated, real-time cell culture analysis with a single-use kit, increasing efficiency, reducing contamination and guaranteeing high-quality results, revolutionizing laboratory work and setting new standards in the field of biotechnology. Ceidos SA is a pioneering biotechnology company based in Monthey, Switzerland and founded in 2019. Specializing in the development of innovative solutions for the biopharmaceutical industry, Ceidos is expert in advanced technologies such as microscopy, microelectronics, and machine learning allowing the development of breakthrough bioprocessing devices. | Ceidos aims to revolutionize biopharmaceutical production with C-Netics, an advanced system for real-time, non-destructive cell culture monitoring. By integrating microscopy, dielectrophoresis, and AI-driven analysis, C-Netics ensures precise control of cell viability, density, and culture conditions. Unlike traditional methods, it connects directly to bioreactors, minimizing contamination risks and reducing manual interventions. Ceidos collaborates with industry leaders and CMOs/CDMOs to optimize bioprocesses, enhance efficiency, and improve the scalability of advanced therapies like CAR-T and monoclonal antibodies.
CDR-Life
At CDR-Life, we are on a mission to transform antibody science into life-changing therapies. Our innovative T cell engager (TCE) platform, M-gager®, delivers therapeutics against challenging targets with unprecedented precision, speed and efficiency. For cancer patients, we are advancing a pipeline of potent and selective TCEs targeting intracellular and surface antigens that empower patients’ own immune systems to eliminate tumors, and our first program has entered the clinic. In autoimmune diseases, we’re using this same breakthrough approach to reset overactive immune responses with pinpoint accuracy. Our platform combines optimized manufacturability with deep scientific expertise and cutting-edge engineering, enabling rapid translation from discovery to scalable production of these complex biologics. This integrated approach helps accelerate the journey from lab to patient treatment, making once-impossible therapeutic goals both achievable and deliverable at scale.
CCRAFT
CCRAFT is a photonic chip manufacturer based on thin-film lithium niobate (TFLN) technology, developed through over six years of R&D at CSEM. We provide monolithic PICs, TFLN chiplets for heterogeneous integration, and TFLN-enhanced silicon photonic wafers processing, delivering scalable, high-performance solutions for telecom, quantum computing, AI, aerospace, and beyond.
CASA 1910
Casa 1910 is a Premium cigar and lifestyle brand that captures the national pride and spirit of the Mexican Revolution. Our objective is to revolutionize the industry by creating a cigar that perfectly embodies the two faces of Mexico: Its deep traditions and its unrivaled dynamism. Position ourselves as the number one brand of Mexican cigars in Mexico and the United States. Our Cigar: Edition: Cuchillo Parado Origin: Valle de San Andrés Tuxtla, Veracruz. Made from a blend of the finest 4 types of San Andrés Negro, aged for a minimum of 5 years. Size: Robusto 5″x50 Strength: Medium body Award winner: Cigar Trophy – Best Cigar 2023